Christian Mirescu

Company: Vigil Neuroscience
Job title: Vice President, Head of Neuroimmunology
Seminars:
TREM2 MOLECULAR GLUES: FIRST-IN-CLASS APPROACH TO TUNING MICROGLIA FOR THE TREATMENT OF ALZHEIMER’S DISEASE 2:30 pm
Potent, selective, orally bioavailable, and brain penetrant small molecule TREM2 agonists Leveraging unique pharmacological profiles for precision modulation of microglial function Building a TREM2 translational strategy with CSF biomarkersRead more
day: Conference Day One
Panel Discussion: Evaluating the Current Landscape of Neuroimmunology Therapeutics & Clinical Development Programs 9:00 am
Outlining neuroimmunology targets currently in clinical development Highlighting implications for future neuroimmunological advancements and novel neuroinflammatory targetingRead more
day: Conference Day One